Phibro Animal Health PAHC Vaccines — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Phibro Animal Health in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phibro Animal Health's vaccines — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phibro Animal Health's vaccines — revenue?
- Phibro Animal Health (PAHC) reported vaccines — revenue of $38.63M in Q1 2026.
- How has Phibro Animal Health's vaccines — revenue changed year-over-year?
- Phibro Animal Health's vaccines — revenue increased by 15.7% year-over-year, from $33.38M to $38.63M.
- What is the long-term trend for Phibro Animal Health's vaccines — revenue?
- Over 4 years (2021 to 2025), Phibro Animal Health's vaccines — revenue has grown at a 17.1% compound annual growth rate (CAGR), from $72.94M to $137.15M.
- What does vaccines — revenue mean?
- This metric represents the total net sales generated from the sale of vaccine products to customers, excluding any collected sales taxes. It serves as a primary indicator of the market demand and commercial success of the company's vaccine portfolio within the animal health segment. Growth in this figure reflects successful product adoption, pricing power, or expansion in the addressable animal health market.